 | • レポートコード：MRC2Q12-19492 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、豚マイコプラズマハイオニューモニエワクチンの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に豚マイコプラズマハイオニューモニエワクチンのグローバル市場のxxx％を占める「豚仮性狂犬病ワクチン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「農場」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 豚マイコプラズマハイオニューモニエワクチンの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの豚マイコプラズマハイオニューモニエワクチン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 豚マイコプラズマハイオニューモニエワクチンのグローバル主要プレイヤーには、Yongshun Creatures、Pfizer、Boehringer Ingelheim、Bayer、Elanco、MSD、Cahic、Ringpu、Baoling、Jizhong、Dahuanong、Keqian Biology、Hayao、Pulike Biology、Teconなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 豚マイコプラズマハイオニューモニエワクチン市場は、種類と用途によって区分されます。世界の豚マイコプラズマハイオニューモニエワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 豚仮性狂犬病ワクチン、生、豚仮性狂犬病ワクチン、不活化 【用途別セグメント】 農場、個人 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 豚マイコプラズマハイオニューモニエワクチン製品概要 - 種類別市場（豚仮性狂犬病ワクチン、生、豚仮性狂犬病ワクチン、不活化） - 用途別市場（農場、個人） - 調査の目的 ・エグゼクティブサマリー - 世界の豚マイコプラズマハイオニューモニエワクチン販売量予測2017-2028 - 世界の豚マイコプラズマハイオニューモニエワクチン売上予測2017-2028 - 豚マイコプラズマハイオニューモニエワクチンの地域別販売量 - 豚マイコプラズマハイオニューモニエワクチンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別豚マイコプラズマハイオニューモニエワクチン販売量 - 主要メーカー別豚マイコプラズマハイオニューモニエワクチン売上 - 主要メーカー別豚マイコプラズマハイオニューモニエワクチン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（豚仮性狂犬病ワクチン、生、豚仮性狂犬病ワクチン、不活化） - 豚マイコプラズマハイオニューモニエワクチンの種類別販売量 - 豚マイコプラズマハイオニューモニエワクチンの種類別売上 - 豚マイコプラズマハイオニューモニエワクチンの種類別価格 ・用途別市場規模（農場、個人） - 豚マイコプラズマハイオニューモニエワクチンの用途別販売量 - 豚マイコプラズマハイオニューモニエワクチンの用途別売上 - 豚マイコプラズマハイオニューモニエワクチンの用途別価格 ・北米市場 - 北米の豚マイコプラズマハイオニューモニエワクチン市場規模（種類別、用途別） - 主要国別の豚マイコプラズマハイオニューモニエワクチン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの豚マイコプラズマハイオニューモニエワクチン市場規模（種類別、用途別） - 主要国別の豚マイコプラズマハイオニューモニエワクチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の豚マイコプラズマハイオニューモニエワクチン市場規模（種類別、用途別） - 主要国別の豚マイコプラズマハイオニューモニエワクチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の豚マイコプラズマハイオニューモニエワクチン市場規模（種類別、用途別） - 主要国別の豚マイコプラズマハイオニューモニエワクチン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの豚マイコプラズマハイオニューモニエワクチン市場規模（種類別、用途別） - 主要国別の豚マイコプラズマハイオニューモニエワクチン市場規模（トルコ、サウジアラビア） ・企業情報 Yongshun Creatures、Pfizer、Boehringer Ingelheim、Bayer、Elanco、MSD、Cahic、Ringpu、Baoling、Jizhong、Dahuanong、Keqian Biology、Hayao、Pulike Biology、Tecon ・産業チェーン及び販売チャネル分析 - 豚マイコプラズマハイオニューモニエワクチンの産業チェーン分析 - 豚マイコプラズマハイオニューモニエワクチンの原材料 - 豚マイコプラズマハイオニューモニエワクチンの生産プロセス - 豚マイコプラズマハイオニューモニエワクチンの販売及びマーケティング - 豚マイコプラズマハイオニューモニエワクチンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 豚マイコプラズマハイオニューモニエワクチンの産業動向 - 豚マイコプラズマハイオニューモニエワクチンのマーケットドライバー - 豚マイコプラズマハイオニューモニエワクチンの課題 - 豚マイコプラズマハイオニューモニエワクチンの阻害要因 ・主な調査結果 |
Biologics for the prevention of mycoplasma pneumonia in pigs
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Swine Mycoplasma Hyopneumoniae Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Swine Mycoplasma Hyopneumoniae Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Swine Mycoplasma Hyopneumoniae Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Swine Mycoplasma Hyopneumoniae Vaccine include Yongshun Creatures, Pfizer, Boehringer Ingelheim, Bayer, Elanco, MSD, Cahic, Ringpu and Baoling, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Swine Mycoplasma Hyopneumoniae Vaccine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Swine Mycoplasma Hyopneumoniae Vaccine market. Further, it explains the major drivers and regional dynamics of the global Swine Mycoplasma Hyopneumoniae Vaccine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Yongshun Creatures
Pfizer
Boehringer Ingelheim
Bayer
Elanco
MSD
Cahic
Ringpu
Baoling
Jizhong
Dahuanong
Keqian Biology
Hayao
Pulike Biology
Tecon
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by activity and by downstream segments based on sales, price, and value for the period 2017-2028.
Swine Mycoplasma Hyopneumoniae Vaccine Segment by Activity
Swine Pseudorabies Vaccine, Live
Swine Pseudorabies Vaccine, Inactivated
Swine Mycoplasma Hyopneumoniae Vaccine Segment by Downstream
Farms
Individual
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Swine Mycoplasma Hyopneumoniae Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Swine Mycoplasma Hyopneumoniae Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Swine Mycoplasma Hyopneumoniae Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Swine Mycoplasma Hyopneumoniae Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Mycoplasma Hyopneumoniae Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Swine Mycoplasma Hyopneumoniae Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Swine Mycoplasma Hyopneumoniae Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Yongshun Creatures, Pfizer, Boehringer Ingelheim, Bayer, Elanco, MSD, Cahic, Ringpu and Baoling, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Swine Mycoplasma Hyopneumoniae Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Swine Mycoplasma Hyopneumoniae Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by activity, by downstream and by country, sales and revenue for each segment.
Chapter 7: Europe by activity, by downstream and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by activity, by downstream and by country, sales and revenue for each segment.
Chapter 9: Latin America by activity, by downstream and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by activity, by downstream and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Mycoplasma Hyopneumoniae Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Swine Mycoplasma Hyopneumoniae Vaccine Product Introduction
1.2 Market by Activity
1.2.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate by Activity, 2017 VS 2021 VS 2028
1.2.2 Swine Pseudorabies Vaccine, Live
1.2.3 Swine Pseudorabies Vaccine, Inactivated
1.3 Market by Downstream
1.3.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate by Downstream, 2017 VS 2021 VS 2028
1.3.2 Farms
1.3.3 Individual
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Region
2.4.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Swine Mycoplasma Hyopneumoniae Vaccine by Region (2023-2028)
2.5 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region
2.5.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2017-2022)
2.5.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Manufacturers
3.1.1 Global Top Swine Mycoplasma Hyopneumoniae Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Swine Mycoplasma Hyopneumoniae Vaccine in 2021
3.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Manufacturers
3.2.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Swine Mycoplasma Hyopneumoniae Vaccine Revenue in 2021
3.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Activity
4.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity
4.1.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Historical Sales by Activity (2017-2022)
4.1.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Forecasted Sales by Activity (2023-2028)
4.1.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Activity (2017-2028)
4.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity
4.2.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Historical Revenue by Activity (2017-2022)
4.2.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Forecasted Revenue by Activity (2023-2028)
4.2.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Activity (2017-2028)
4.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Price by Activity
4.3.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Price by Activity (2017-2022)
4.3.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Price Forecast by Activity (2023-2028)
5 Market Size by Downstream
5.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream
5.1.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Historical Sales by Downstream (2017-2022)
5.1.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Forecasted Sales by Downstream (2023-2028)
5.1.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Downstream (2017-2028)
5.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream
5.2.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Historical Revenue by Downstream (2017-2022)
5.2.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Forecasted Revenue by Downstream (2023-2028)
5.2.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Downstream (2017-2028)
5.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Price by Downstream
5.3.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Price by Downstream (2017-2022)
5.3.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Price Forecast by Downstream (2023-2028)
6 North America
6.1 North America Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Activity
6.1.1 North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2028)
6.1.2 North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2028)
6.2 North America Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Downstream
6.2.1 North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2028)
6.2.2 North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2028)
6.3 North America Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Country
6.3.1 North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2028)
6.3.2 North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Activity
7.1.1 Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2028)
7.1.2 Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2028)
7.2 Europe Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Downstream
7.2.1 Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2028)
7.2.2 Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2028)
7.3 Europe Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Country
7.3.1 Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2028)
7.3.2 Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Activity
8.1.1 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2028)
8.1.2 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2028)
8.2 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Downstream
8.2.1 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2028)
8.2.2 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2028)
8.3 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Region
8.3.1 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Activity
9.1.1 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2028)
9.1.2 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2028)
9.2 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Downstream
9.2.1 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2028)
9.2.2 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2028)
9.3 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Country
9.3.1 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Activity
10.1.1 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2028)
10.1.2 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2028)
10.2 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Downstream
10.2.1 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2028)
10.2.2 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2028)
10.3 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Market Size by Country
10.3.1 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Yongshun Creatures
11.1.1 Yongshun Creatures Corporation Information
11.1.2 Yongshun Creatures Overview
11.1.3 Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Yongshun Creatures Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Overview
11.4.3 Bayer Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bayer Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Recent Developments
11.5 Elanco
11.5.1 Elanco Corporation Information
11.5.2 Elanco Overview
11.5.3 Elanco Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Elanco Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elanco Recent Developments
11.6 MSD
11.6.1 MSD Corporation Information
11.6.2 MSD Overview
11.6.3 MSD Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 MSD Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 MSD Recent Developments
11.7 Cahic
11.7.1 Cahic Corporation Information
11.7.2 Cahic Overview
11.7.3 Cahic Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cahic Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cahic Recent Developments
11.8 Ringpu
11.8.1 Ringpu Corporation Information
11.8.2 Ringpu Overview
11.8.3 Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ringpu Recent Developments
11.9 Baoling
11.9.1 Baoling Corporation Information
11.9.2 Baoling Overview
11.9.3 Baoling Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Baoling Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Baoling Recent Developments
11.10 Jizhong
11.10.1 Jizhong Corporation Information
11.10.2 Jizhong Overview
11.10.3 Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jizhong Recent Developments
11.11 Dahuanong
11.11.1 Dahuanong Corporation Information
11.11.2 Dahuanong Overview
11.11.3 Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dahuanong Recent Developments
11.12 Keqian Biology
11.12.1 Keqian Biology Corporation Information
11.12.2 Keqian Biology Overview
11.12.3 Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Keqian Biology Recent Developments
11.13 Hayao
11.13.1 Hayao Corporation Information
11.13.2 Hayao Overview
11.13.3 Hayao Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hayao Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hayao Recent Developments
11.14 Pulike Biology
11.14.1 Pulike Biology Corporation Information
11.14.2 Pulike Biology Overview
11.14.3 Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pulike Biology Recent Developments
11.15 Tecon
11.15.1 Tecon Corporation Information
11.15.2 Tecon Overview
11.15.3 Tecon Swine Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Tecon Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tecon Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Swine Mycoplasma Hyopneumoniae Vaccine Industry Chain Analysis
12.2 Swine Mycoplasma Hyopneumoniae Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Swine Mycoplasma Hyopneumoniae Vaccine Production Mode & Process
12.4 Swine Mycoplasma Hyopneumoniae Vaccine Sales and Marketing
12.4.1 Swine Mycoplasma Hyopneumoniae Vaccine Sales Channels
12.4.2 Swine Mycoplasma Hyopneumoniae Vaccine Distributors
12.5 Swine Mycoplasma Hyopneumoniae Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Swine Mycoplasma Hyopneumoniae Vaccine Industry Trends
13.2 Swine Mycoplasma Hyopneumoniae Vaccine Market Drivers
13.3 Swine Mycoplasma Hyopneumoniae Vaccine Market Challenges
13.4 Swine Mycoplasma Hyopneumoniae Vaccine Market Restraints
14 Key Findings in The Global Swine Mycoplasma Hyopneumoniae Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate by Activity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Swine Pseudorabies Vaccine, Live
Table 3. Major Manufacturers of Swine Pseudorabies Vaccine, Inactivated
Table 4. Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size Growth Rate by Downstream, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Region (2017-2022) & (Box)
Table 7. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Region (2023-2028) & (Box)
Table 9. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Manufacturers (2017-2022) & (Box)
Table 15. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Swine Mycoplasma Hyopneumoniae Vaccine Price by Manufacturers (2017-2022) &(US$/Box)
Table 19. Global Swine Mycoplasma Hyopneumoniae Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Swine Mycoplasma Hyopneumoniae Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Mycoplasma Hyopneumoniae Vaccine as of 2021)
Table 21. Swine Mycoplasma Hyopneumoniae Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Swine Mycoplasma Hyopneumoniae Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Swine Mycoplasma Hyopneumoniae Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2022) & (Box)
Table 26. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2023-2028) & (Box)
Table 27. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Activity (2017-2022)
Table 28. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Activity (2023-2028)
Table 29. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2022) & (US$ Million)
Table 30. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2023-2028) & (US$ Million)
Table 31. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Activity (2017-2022)
Table 32. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Activity (2023-2028)
Table 33. Swine Mycoplasma Hyopneumoniae Vaccine Price by Activity (2017-2022) & (US$/Box)
Table 34. Global Swine Mycoplasma Hyopneumoniae Vaccine Price Forecast by Activity (2023-2028) & (US$/Box)
Table 35. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2022) & (Box)
Table 36. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2023-2028) & (Box)
Table 37. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Downstream (2017-2022)
Table 38. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Downstream (2023-2028)
Table 39. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2022) & (US$ Million)
Table 40. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2023-2028) & (US$ Million)
Table 41. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Downstream (2017-2022)
Table 42. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Downstream (2023-2028)
Table 43. Swine Mycoplasma Hyopneumoniae Vaccine Price by Downstream (2017-2022) & (US$/Box)
Table 44. Global Swine Mycoplasma Hyopneumoniae Vaccine Price Forecast by Downstream (2023-2028) & (US$/Box)
Table 45. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2022) & (Box)
Table 46. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2023-2028) & (Box)
Table 47. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2022) & (US$ Million)
Table 48. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2023-2028) & (US$ Million)
Table 49. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2022) & (Box)
Table 50. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2023-2028) & (Box)
Table 51. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2022) & (US$ Million)
Table 52. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2023-2028) & (US$ Million)
Table 53. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022) & (Box)
Table 54. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2023-2028) & (Box)
Table 55. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2022) & (Box)
Table 58. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2023-2028) & (Box)
Table 59. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2022) & (US$ Million)
Table 60. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2023-2028) & (US$ Million)
Table 61. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2022) & (Box)
Table 62. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2023-2028) & (Box)
Table 63. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2022) & (US$ Million)
Table 64. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2023-2028) & (US$ Million)
Table 65. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022) & (Box)
Table 66. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2023-2028) & (Box)
Table 67. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2022) & (Box)
Table 70. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2023-2028) & (Box)
Table 71. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2022) & (US$ Million)
Table 72. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2023-2028) & (US$ Million)
Table 73. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2022) & (Box)
Table 74. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2023-2028) & (Box)
Table 75. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2022) & (US$ Million)
Table 76. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2023-2028) & (US$ Million)
Table 77. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Region (2017-2022) & (Box)
Table 78. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales by Region (2023-2028) & (Box)
Table 79. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2022) & (Box)
Table 82. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2023-2028) & (Box)
Table 83. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2022) & (US$ Million)
Table 84. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2023-2028) & (US$ Million)
Table 85. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2022) & (Box)
Table 86. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2023-2028) & (Box)
Table 87. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2022) & (US$ Million)
Table 88. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2023-2028) & (US$ Million)
Table 89. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022) & (Box)
Table 90. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2023-2028) & (Box)
Table 91. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2017-2022) & (Box)
Table 94. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Activity (2023-2028) & (Box)
Table 95. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Activity (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2017-2022) & (Box)
Table 98. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Downstream (2023-2028) & (Box)
Table 99. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Downstream (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022) & (Box)
Table 102. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales by Country (2023-2028) & (Box)
Table 103. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Yongshun Creatures Corporation Information
Table 106. Yongshun Creatures Description and Major Businesses
Table 107. Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 108. Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Yongshun Creatures Recent Developments
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 113. Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Pfizer Recent Developments
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 118. Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Major Businesses
Table 122. Bayer Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 123. Bayer Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bayer Recent Developments
Table 125. Elanco Corporation Information
Table 126. Elanco Description and Major Businesses
Table 127. Elanco Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 128. Elanco Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Elanco Recent Developments
Table 130. MSD Corporation Information
Table 131. MSD Description and Major Businesses
Table 132. MSD Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 133. MSD Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. MSD Recent Developments
Table 135. Cahic Corporation Information
Table 136. Cahic Description and Major Businesses
Table 137. Cahic Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 138. Cahic Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Cahic Recent Developments
Table 140. Ringpu Corporation Information
Table 141. Ringpu Description and Major Businesses
Table 142. Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 143. Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Ringpu Recent Developments
Table 145. Baoling Corporation Information
Table 146. Baoling Description and Major Businesses
Table 147. Baoling Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 148. Baoling Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Baoling Recent Developments
Table 150. Jizhong Corporation Information
Table 151. Jizhong Description and Major Businesses
Table 152. Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 153. Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Jizhong Recent Developments
Table 155. Dahuanong Corporation Information
Table 156. Dahuanong Description and Major Businesses
Table 157. Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 158. Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Dahuanong Recent Developments
Table 160. Keqian Biology Corporation Information
Table 161. Keqian Biology Description and Major Businesses
Table 162. Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 163. Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Keqian Biology Recent Developments
Table 165. Hayao Corporation Information
Table 166. Hayao Description and Major Businesses
Table 167. Hayao Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 168. Hayao Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Hayao Recent Developments
Table 170. Pulike Biology Corporation Information
Table 171. Pulike Biology Description and Major Businesses
Table 172. Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 173. Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Pulike Biology Recent Developments
Table 175. Tecon Corporation Information
Table 176. Tecon Description and Major Businesses
Table 177. Tecon Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 178. Tecon Swine Mycoplasma Hyopneumoniae Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Tecon Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Swine Mycoplasma Hyopneumoniae Vaccine Distributors List
Table 183. Swine Mycoplasma Hyopneumoniae Vaccine Customers List
Table 184. Swine Mycoplasma Hyopneumoniae Vaccine Market Trends
Table 185. Swine Mycoplasma Hyopneumoniae Vaccine Market Drivers
Table 186. Swine Mycoplasma Hyopneumoniae Vaccine Market Challenges
Table 187. Swine Mycoplasma Hyopneumoniae Vaccine Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Mycoplasma Hyopneumoniae Vaccine Product Picture
Figure 2. Global Swine Mycoplasma Hyopneumoniae Vaccine Market Share by Activity in 2021 & 2028
Figure 3. Swine Pseudorabies Vaccine, Live Product Picture
Figure 4. Swine Pseudorabies Vaccine, Inactivated Product Picture
Figure 5. Global Swine Mycoplasma Hyopneumoniae Vaccine Market Share by Downstream in 2021 & 2028
Figure 6. Farms
Figure 7. Individual
Figure 8. Swine Mycoplasma Hyopneumoniae Vaccine Report Years Considered
Figure 9. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales 2017-2028 (Box)
Figure 10. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue 2017-2028 (US$ Million)
Figure 12. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2023-2028)
Figure 15. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales YoY (2017-2028) & (Box)
Figure 16. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales YoY (2017-2028) & (Box)
Figure 18. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales YoY (2017-2028) & (Box)
Figure 20. Asia-Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales YoY (2017-2028) & (Box)
Figure 22. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales YoY (2017-2028) & (Box)
Figure 24. Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Swine Mycoplasma Hyopneumoniae Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Swine Mycoplasma Hyopneumoniae Vaccine in the World: Market Share by Swine Mycoplasma Hyopneumoniae Vaccine Revenue in 2021
Figure 27. Global Swine Mycoplasma Hyopneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Activity (2017-2028)
Figure 29. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Activity (2017-2028)
Figure 30. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Downstream (2017-2028)
Figure 31. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Downstream (2017-2028)
Figure 32. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Activity (2017-2028)
Figure 33. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Activity (2017-2028)
Figure 34. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Downstream (2017-2028)
Figure 35. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Downstream (2017-2028)
Figure 36. North America Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Country (2017-2028)
Figure 37. North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country (2017-2028)
Figure 38. United States Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Activity (2017-2028)
Figure 41. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Activity (2017-2028)
Figure 42. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Downstream (2017-2028)
Figure 43. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Downstream (2017-2028)
Figure 44. Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Country (2017-2028)
Figure 45. Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country (2017-2028)
Figure 46. Germany Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. France Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Activity (2017-2028)
Figure 52. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Activity (2017-2028)
Figure 53. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Downstream (2017-2028)
Figure 54. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Downstream (2017-2028)
Figure 55. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Region (2017-2028)
Figure 57. China Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. India Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Activity (2017-2028)
Figure 67. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Activity (2017-2028)
Figure 68. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Downstream (2017-2028)
Figure 69. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Downstream (2017-2028)
Figure 70. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Country (2017-2028)
Figure 71. Latin America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country (2017-2028)
Figure 72. Mexico Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Activity (2017-2028)
Figure 76. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Activity (2017-2028)
Figure 77. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Downstream (2017-2028)
Figure 78. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Downstream (2017-2028)
Figure 79. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country (2017-2028)
Figure 81. Turkey Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Swine Mycoplasma Hyopneumoniae Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Swine Mycoplasma Hyopneumoniae Vaccine Value Chain
Figure 85. Swine Mycoplasma Hyopneumoniae Vaccine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed